This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Institute of Pharmaceutical Industry. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Chengjin Shi: Innovator in Antidepressant Research
Introduction
Chengjin Shi is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidepressant compounds. His innovative work has the potential to improve the treatment of depression, a condition that affects millions worldwide.
Latest Patents
Chengjin Shi holds a patent for "Aralkyl-alcohol piperazine derivatives and their uses as antidepressant." This patent describes aryl alkanol piperazine derivatives and pharmaceutical compositions that include these compounds. The invention outlines methods for treating depression using the pharmaceutical composition. The compounds developed by Chengjin Shi exhibit excellent dual inhibitory actions on the uptake of monoamine neurotransmitters, demonstrating good antidepressant activities with minimal side effects. He has 1 patent to his name.
Career Highlights
Chengjin Shi is affiliated with the Shanghai Institute of Pharmaceutical Industry, where he conducts his research and development activities. His work focuses on creating effective pharmaceutical solutions that address mental health issues.
Collaborations
Chengjin Shi collaborates with notable colleagues, including Wenxin Dong and Liying Huang. Their combined expertise enhances the research efforts at the Shanghai Institute of Pharmaceutical Industry.
Conclusion
Chengjin Shi's contributions to antidepressant research highlight his role as an innovator in the pharmaceutical industry. His patented work has the potential to significantly impact the treatment of depression, showcasing the importance of continued research in this vital area.